The S&P 500 (SPX) has surpassed its previous high among a global pandemic and an uncertain economy. The index is up almost 11% year-to-date, as investors anticipate more good news regarding a COVID-19 vaccine. Nonetheless, it proved a strange week in price action terms as Monday’s 4% gap up was almost erased by the end of the day. When the…
Get Back Up: Now, What Did You Learn?
A financial market resource for the every-day investor and trader.
-
It May Be Time To Back Up Before Next Leg Higher?
Seth Golden, , Research Reports, 0
In the week that was, the S&P 500 (SPX) found itself another leg higher, capturing new record-level highs and...
-
-
Bear Market Has Weakened, But The Market Gauntlet Is Still Formidable
Seth Golden, , Research Reports, 0
It’s difficult to be too optimistic with another 75bps rate hike (almost certainly) coming next week, and especially given...
-
-
IDENTIFYING BEAR MARKET BOTTOMS AND NEW BULL MARKETS
Seth Golden, , Research Reports, 0
Paul F. Desmond Lowry’s Reports Inc. 26 February 2002 Ask one hundred investors whether this is a bull...
-
J.P. Morgan Mid-Year Outlook
Seth Golden, , Research Reports, 0
2020 Mid-Year Outlook for Economies and Markets as the World Re-opens Summary and Replay of 2020 Mid-Year Outlook Virtual...
-
Weekly State of the Market: Cloudy Markets With High Probability of Sunshine Forecast
Seth Golden, , Research Reports, 0
Maintaining good disciplines during price consolidation periods: 1. Are the “yea buts” greater than a self-induced economic shutdown and...
-
Lead Biotech Analysts Updates Vaccine Forecast
Seth Golden, , Research Reports, 0
Pfizer has not yet accrued the32 COVID infections for its 1st interim analysis: The fact that Pfizer’s first interim...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00